default author photo

Tessa G. Steenbruggen

Netherlands Cancer Institute

Plesmanlaan 121

Amsterdam, 1066 CX

Netherlands

  • Netherlands Cancer Institute

SCHOLARLY PAPERS

1

DOWNLOADS

26

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Intensified Alkylating Chemotherapy for Patients with Oligometastatic Breast Cancer Harboring Homologous Recombination Deficiency: Primary Outcomes from the Randomized Phase III Oligo Study

Number of pages: 29 Posted: 24 Jul 2024
Annemiek van Ommen-Nijhof, Tessa G. Steenbruggen, Terry G. Wiersma, Sara Balduzzi, Antonios Daletzakis, Marjo J. Holtkamp, Marjolein Delfos, Margaret Schot, Karin Beelen, Ester J.M. Siemerink, Joan Heijns, Ingrid A. Mandjes, Jelle Wesseling, Efraim H. Rosenberg, Marie-Jeanne T.F.D. Vrancken Peeters, SAbine Linn and Gabe Sonke
Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Rijnstate Hospital, Netherlands Cancer Institute, Amphia Hospital, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute and Netherlands Cancer Institute
Downloads 26 (1,372,601)

Abstract:

Loading...

oligometastatic breast cancer, homologous recombination deficiency, intensified alkylating chemotherapy, multimodality treatment